Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Will Harvard's gene therapy for Diamond-Blackfan Anemia receive FDA approval by end of 2025?  | Binary | 4 | 1 month ago | ||
Will Gilead's Livdelzi launch commercially in the US by mid-2025? | Binary | 2 | 1 month ago | ||
Will Intellia's CRISPR treatment for ATTR enter Phase 2 trials by end of November 2025? | Binary | 2 | 1 month ago | ||
What will be the outcome of Gilead's Livdelzi Phase 3 study for PBC by end of 2024? | Categorical | 2 | 1 month ago | ||
What will be the dominant therapeutic approach for Diamond-Blackfan Anemia by 2026? | Categorical | 2 | 1 month ago | ||
What will be the primary outcome of Intellia's CRISPR treatment Phase 1 study for ATTR by end of 2024? | Categorical | 2 | 1 month ago |